Tamma Pranita D, Holmes Alison, Ashley Elizabeth Dodds
aDivision of Pediatric Infectious Diseases, Department of Pediatrics, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA bFaculty of Medicine, National Centre for Infection Prevention and Management, Imperial College, London, UK cAssociate Director of Clinical Pharmacy Services, University of Rochester Medical Center, Rochester, New York, USA.
Curr Opin Infect Dis. 2014 Aug;27(4):348-55. doi: 10.1097/QCO.0000000000000077.
This review describes the overlapping aspects of antimicrobial stewardship and patient-safety initiatives and justifies why stewardship belongs under the umbrella of patient safety.
Addressing the continued emergence of antibiotic resistance through the discovery of new drugs is not a sustainable strategy, particularly as antibiotics are increasingly more difficult and costly to develop. Thus, it is essential that we preserve the utility of existing antibiotics. Antimicrobial stewardship programs can assist with achieving this goal. Currently, however, the term 'antimicrobial stewardship' is generally not easily understood by regulators, hospital administrators, or the public. Perhaps more clout would be given to antimicrobial stewardship if it is associated with safety. In this review, we present concrete examples of how antimicrobial stewardship programs can focus on achieving goals already recognized as essential for patient safety.
Patient safety is an integral component of antimicrobial stewardship. To make the concept of antimicrobial stewardship more palatable, the association between antimicrobial stewardship and safety needs to be emphasized.
本综述描述了抗菌药物管理与患者安全倡议的重叠方面，并论证了为何抗菌药物管理属于患者安全的范畴。
通过研发新药来应对抗生素耐药性的持续出现并非可持续战略，尤其是随着抗生素研发难度越来越大且成本越来越高。因此，我们必须保留现有抗生素的效用。抗菌药物管理计划有助于实现这一目标。然而，目前监管机构、医院管理人员或公众通常不太容易理解“抗菌药物管理”一词。如果将抗菌药物管理与安全联系起来，或许会更有影响力。在本综述中，我们给出了具体例子，说明抗菌药物管理计划如何能够专注于实现已被公认为对患者安全至关重要的目标。
患者安全是抗菌药物管理的一个组成部分。为了使抗菌药物管理的概念更容易被接受，需要强调抗菌药物管理与安全之间的关联。
